| Literature DB >> 33989520 |
Fuad J Naser1, Madelyn M Jackstadt1, Ronald Fowle-Grider1, Jonathan L Spalding2, Kevin Cho1, Ethan Stancliffe1, Steven R Doonan1, Eva T Kramer3, Lijun Yao4, Bradley Krasnick5, Li Ding6, Ryan C Fields5, Charles K Kaufman7, Leah P Shriver1, Stephen L Johnson8, Gary J Patti9.
Abstract
The cell-intrinsic nature of tumor metabolism has become increasingly well characterized. The impact that tumors have on systemic metabolism, however, has received less attention. Here, we used adult zebrafish harboring BRAFV600E-driven melanoma to study the effect of cancer on distant tissues. By applying metabolomics and isotope tracing, we found that melanoma consume ~15 times more glucose than other tissues measured. Despite this burden, circulating glucose levels were maintained in disease animals by a tumor-liver alanine cycle. Excretion of glucose-derived alanine from tumors provided a source of carbon for hepatic gluconeogenesis and allowed tumors to remove excess nitrogen from branched-chain amino acid catabolism, which we found to be activated in zebrafish and human melanoma. Pharmacological inhibition of the tumor-liver alanine cycle in zebrafish reduced tumor burden. Our findings underscore the significance of metabolic crosstalk between tumors and distant tissues and establish the adult zebrafish as an attractive model to study such processes.Entities:
Keywords: alanine cycle; cancer; cancer metabolism; isotope tracing; melanoma; metabolite exchange; metabolomics; zebrafish
Mesh:
Substances:
Year: 2021 PMID: 33989520 PMCID: PMC9275394 DOI: 10.1016/j.cmet.2021.04.014
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 31.373